Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development - Concepedia

Concepedia

Publication | Open Access

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

DOI Full Paper Access

116

Citations

53

References

2016

Year

Ma Carmen Herrero‐Sánchez, Concepción Rodríguez‐Serrano, Júlia Almeida, Laura San‐Segundo, Susana Inogés, Ángel Santos‐Briz, Jesús G. Briñón, Luís A. Corchete, Jesús F. San Miguel, Consuelo del Cañizo,

Journal of Hematology & Oncology

Abstract

These results support the use of PI3K inhibitors to control T cell responses and show the potential utility of the dual PI3K/mTOR inhibitor BEZ235 in GvHD prophylaxis.

References

	Year	Citations

Page 1